Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing

Daniel Trujillano, Belén Perez, Justo González, Cristian Tornador, Rosa Navarrete, Georgia Escaramis, Stephan Ossowski, Lluís Armengol, Verónica Cornejo, Lourdes R. Desviat, Magdalena Ugarte, Xavier P. Estivill

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Genetic diagnostics of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficient hyperphenylalaninemia (BH4DH) rely on methods that scan for known mutations or on laborious molecular tools that use Sanger sequencing. We have implemented a novel and much more efficient strategy based on high-throughput multiplex-targeted resequencing of four genes (PAH, GCH1, PTS, and QDPR) that, when affected by loss-of-function mutations, cause PKU and BH4DH. We have validated this approach in a cohort of 95 samples with the previously known PAH, GCH1, PTS, and QDPR mutations and one control sample. Pooled barcoded DNA libraries were enriched using a custom NimbleGen SeqCap EZ Choice array and sequenced using a HiSeq2000 sequencer. The combination of several robust bioinformatics tools allowed us to detect all known pathogenic mutations (point mutations, short insertions/deletions, and large genomic rearrangements) in the 95 samples, without detecting spurious calls in these genes in the control sample. We then used the same capture assay in a discovery cohort of 11 uncharacterized HPA patients using a MiSeq sequencer. In addition, we report the precise characterization of the breakpoints of four genomic rearrangements in PAH, including a novel deletion of 899 bp in intron 3. Our study is a proof-of-principle that high-throughput-targeted resequencing is ready to substitute classical molecular methods to perform differential genetic diagnosis of hyperphenylalaninemias, allowing the establishment of specifically tailored treatments a few days after birth.

Original languageEnglish
Pages (from-to)528-534
Number of pages7
JournalEuropean Journal of Human Genetics
Volume22
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Phenylketonurias
Mutation
Computational Biology
Gene Library
Point Mutation
Introns
Genes
Differential Diagnosis
Parturition
sapropterin
Therapeutics

Keywords

  • Genetic counseling
  • Hyperphenylalaninemia
  • Molecular diagnostics
  • Phenylketonuria
  • Targeted resequencing
  • Tetrahydrobiopterin deficiency

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing. / Trujillano, Daniel; Perez, Belén; González, Justo; Tornador, Cristian; Navarrete, Rosa; Escaramis, Georgia; Ossowski, Stephan; Armengol, Lluís; Cornejo, Verónica; Desviat, Lourdes R.; Ugarte, Magdalena; Estivill, Xavier P.

In: European Journal of Human Genetics, Vol. 22, No. 4, 2014, p. 528-534.

Research output: Contribution to journalArticle

Trujillano, D, Perez, B, González, J, Tornador, C, Navarrete, R, Escaramis, G, Ossowski, S, Armengol, L, Cornejo, V, Desviat, LR, Ugarte, M & Estivill, XP 2014, 'Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing', European Journal of Human Genetics, vol. 22, no. 4, pp. 528-534. https://doi.org/10.1038/ejhg.2013.175
Trujillano, Daniel ; Perez, Belén ; González, Justo ; Tornador, Cristian ; Navarrete, Rosa ; Escaramis, Georgia ; Ossowski, Stephan ; Armengol, Lluís ; Cornejo, Verónica ; Desviat, Lourdes R. ; Ugarte, Magdalena ; Estivill, Xavier P. / Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing. In: European Journal of Human Genetics. 2014 ; Vol. 22, No. 4. pp. 528-534.
@article{93cd5e6119f840c2a2552bd6b76270de,
title = "Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing",
abstract = "Genetic diagnostics of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficient hyperphenylalaninemia (BH4DH) rely on methods that scan for known mutations or on laborious molecular tools that use Sanger sequencing. We have implemented a novel and much more efficient strategy based on high-throughput multiplex-targeted resequencing of four genes (PAH, GCH1, PTS, and QDPR) that, when affected by loss-of-function mutations, cause PKU and BH4DH. We have validated this approach in a cohort of 95 samples with the previously known PAH, GCH1, PTS, and QDPR mutations and one control sample. Pooled barcoded DNA libraries were enriched using a custom NimbleGen SeqCap EZ Choice array and sequenced using a HiSeq2000 sequencer. The combination of several robust bioinformatics tools allowed us to detect all known pathogenic mutations (point mutations, short insertions/deletions, and large genomic rearrangements) in the 95 samples, without detecting spurious calls in these genes in the control sample. We then used the same capture assay in a discovery cohort of 11 uncharacterized HPA patients using a MiSeq sequencer. In addition, we report the precise characterization of the breakpoints of four genomic rearrangements in PAH, including a novel deletion of 899 bp in intron 3. Our study is a proof-of-principle that high-throughput-targeted resequencing is ready to substitute classical molecular methods to perform differential genetic diagnosis of hyperphenylalaninemias, allowing the establishment of specifically tailored treatments a few days after birth.",
keywords = "Genetic counseling, Hyperphenylalaninemia, Molecular diagnostics, Phenylketonuria, Targeted resequencing, Tetrahydrobiopterin deficiency",
author = "Daniel Trujillano and Bel{\'e}n Perez and Justo Gonz{\'a}lez and Cristian Tornador and Rosa Navarrete and Georgia Escaramis and Stephan Ossowski and Llu{\'i}s Armengol and Ver{\'o}nica Cornejo and Desviat, {Lourdes R.} and Magdalena Ugarte and Estivill, {Xavier P.}",
year = "2014",
doi = "10.1038/ejhg.2013.175",
language = "English",
volume = "22",
pages = "528--534",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin- deficient hyperphenylalaninemias using high-throughput targeted sequencing

AU - Trujillano, Daniel

AU - Perez, Belén

AU - González, Justo

AU - Tornador, Cristian

AU - Navarrete, Rosa

AU - Escaramis, Georgia

AU - Ossowski, Stephan

AU - Armengol, Lluís

AU - Cornejo, Verónica

AU - Desviat, Lourdes R.

AU - Ugarte, Magdalena

AU - Estivill, Xavier P.

PY - 2014

Y1 - 2014

N2 - Genetic diagnostics of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficient hyperphenylalaninemia (BH4DH) rely on methods that scan for known mutations or on laborious molecular tools that use Sanger sequencing. We have implemented a novel and much more efficient strategy based on high-throughput multiplex-targeted resequencing of four genes (PAH, GCH1, PTS, and QDPR) that, when affected by loss-of-function mutations, cause PKU and BH4DH. We have validated this approach in a cohort of 95 samples with the previously known PAH, GCH1, PTS, and QDPR mutations and one control sample. Pooled barcoded DNA libraries were enriched using a custom NimbleGen SeqCap EZ Choice array and sequenced using a HiSeq2000 sequencer. The combination of several robust bioinformatics tools allowed us to detect all known pathogenic mutations (point mutations, short insertions/deletions, and large genomic rearrangements) in the 95 samples, without detecting spurious calls in these genes in the control sample. We then used the same capture assay in a discovery cohort of 11 uncharacterized HPA patients using a MiSeq sequencer. In addition, we report the precise characterization of the breakpoints of four genomic rearrangements in PAH, including a novel deletion of 899 bp in intron 3. Our study is a proof-of-principle that high-throughput-targeted resequencing is ready to substitute classical molecular methods to perform differential genetic diagnosis of hyperphenylalaninemias, allowing the establishment of specifically tailored treatments a few days after birth.

AB - Genetic diagnostics of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficient hyperphenylalaninemia (BH4DH) rely on methods that scan for known mutations or on laborious molecular tools that use Sanger sequencing. We have implemented a novel and much more efficient strategy based on high-throughput multiplex-targeted resequencing of four genes (PAH, GCH1, PTS, and QDPR) that, when affected by loss-of-function mutations, cause PKU and BH4DH. We have validated this approach in a cohort of 95 samples with the previously known PAH, GCH1, PTS, and QDPR mutations and one control sample. Pooled barcoded DNA libraries were enriched using a custom NimbleGen SeqCap EZ Choice array and sequenced using a HiSeq2000 sequencer. The combination of several robust bioinformatics tools allowed us to detect all known pathogenic mutations (point mutations, short insertions/deletions, and large genomic rearrangements) in the 95 samples, without detecting spurious calls in these genes in the control sample. We then used the same capture assay in a discovery cohort of 11 uncharacterized HPA patients using a MiSeq sequencer. In addition, we report the precise characterization of the breakpoints of four genomic rearrangements in PAH, including a novel deletion of 899 bp in intron 3. Our study is a proof-of-principle that high-throughput-targeted resequencing is ready to substitute classical molecular methods to perform differential genetic diagnosis of hyperphenylalaninemias, allowing the establishment of specifically tailored treatments a few days after birth.

KW - Genetic counseling

KW - Hyperphenylalaninemia

KW - Molecular diagnostics

KW - Phenylketonuria

KW - Targeted resequencing

KW - Tetrahydrobiopterin deficiency

UR - http://www.scopus.com/inward/record.url?scp=84896542286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896542286&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2013.175

DO - 10.1038/ejhg.2013.175

M3 - Article

VL - 22

SP - 528

EP - 534

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 4

ER -